1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow Combivent CFC-MDI: new trials by email Literature Review of Combivent CFC-MDI trials Research Report on Combivent CFC-MDI
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Combivent Respimat 1-year Safety Study in Patients With Chronic Obstructive Pulmonary Disease Combivent CFC-MDI, Combivent Respimat 20/100 mcg, Atrovent HFA 42 mcg + Albuterol HFA 200 mcg - Pulmonary Disease, Chronic Obstructive | Phase 3 | Completed | Boehringer Ingelheim | 470 | 2009-11-01 | 2014-10-23 |
Pulmonary Disease, Chronic Obstructive (1)
United States (1)